NTLA
Price
$10.70
Change
+$1.06 (+11.00%)
Updated
Feb 14 closing price
Capitalization
1.09B
5 days until earnings call
VERV
Price
$8.58
Change
+$0.87 (+11.28%)
Updated
Feb 14 closing price
Capitalization
726.42M
11 days until earnings call
Ad is loading...

NTLA vs VERV

Header iconNTLA vs VERV Comparison
Open Charts NTLA vs VERVBanner chart's image
Intellia Therapeutics
Price$10.70
Change+$1.06 (+11.00%)
Volume$4.75M
Capitalization1.09B
Verve Therapeutics
Price$8.58
Change+$0.87 (+11.28%)
Volume$1.41M
Capitalization726.42M
NTLA vs VERV Comparison Chart
Loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NTLA vs. VERV commentary
Feb 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTLA is a StrongBuy and VERV is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 16, 2025
Stock price -- (NTLA: $10.70 vs. VERV: $8.58)
Brand notoriety: NTLA and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NTLA: 170% vs. VERV: 90%
Market capitalization -- NTLA: $1.09B vs. VERV: $726.42M
NTLA [@Biotechnology] is valued at $1.09B. VERV’s [@Biotechnology] market capitalization is $726.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $350B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTLA’s FA Score shows that 1 FA rating(s) are green whileVERV’s FA Score has 0 green FA rating(s).

  • NTLA’s FA Score: 1 green, 4 red.
  • VERV’s FA Score: 0 green, 5 red.
According to our system of comparison, VERV is a better buy in the long-term than NTLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTLA’s TA Score shows that 6 TA indicator(s) are bullish while VERV’s TA Score has 4 bullish TA indicator(s).

  • NTLA’s TA Score: 6 bullish, 2 bearish.
  • VERV’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than VERV.

Price Growth

NTLA (@Biotechnology) experienced а +9.30% price change this week, while VERV (@Biotechnology) price change was +5.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.17%. For the same industry, the average monthly price growth was +1.27%, and the average quarterly price growth was +6.50%.

Reported Earning Dates

NTLA is expected to report earnings on May 01, 2025.

VERV is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (+1.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($1.09B) has a higher market cap than VERV($726M). VERV YTD gains are higher at: 52.128 vs. NTLA (-8.233). VERV has higher annual earnings (EBITDA): -219.97M vs. NTLA (-527.52M). NTLA has more cash in the bank: 658M vs. VERV (540M). VERV has less debt than NTLA: VERV (71.3M) vs NTLA (102M). NTLA has higher revenues than VERV: NTLA (43.1M) vs VERV (24.4M).
NTLAVERVNTLA / VERV
Capitalization1.09B726M150%
EBITDA-527.52M-219.97M240%
Gain YTD-8.23352.128-16%
P/E RatioN/AN/A-
Revenue43.1M24.4M177%
Total Cash658M540M122%
Total Debt102M71.3M143%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NTLAVERV
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 11 days ago
87%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Ad is loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MEQFX21.24N/A
N/A
AMG River Road Large Cap Value Select I
FMIMX38.41N/A
N/A
FMI Common Stock Investor
GILIX20.80N/A
N/A
NAA Large Core Instl
MLRSX12.71N/A
N/A
NYLI Winslow Large Cap Growth Class R6
BIDVX14.56-0.04
-0.27%
BlackRock GA Disciplined Vol Eq Instl

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with VCYT. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
+11.00%
VCYT - NTLA
69%
Closely correlated
+3.84%
BEAM - NTLA
62%
Loosely correlated
+13.25%
EDIT - NTLA
61%
Loosely correlated
+12.20%
CRSP - NTLA
61%
Loosely correlated
+14.33%
ALLO - NTLA
59%
Loosely correlated
+44.68%
More

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with BEAM. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
+11.28%
BEAM - VERV
55%
Loosely correlated
+13.25%
CRSP - VERV
53%
Loosely correlated
+14.33%
NTLA - VERV
50%
Loosely correlated
+11.00%
EDIT - VERV
49%
Loosely correlated
+12.20%
PRME - VERV
48%
Loosely correlated
+9.44%
More